Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03741153
Other study ID # PXSDM
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date January 2019
Est. completion date March 14, 2021

Study information

Verified date November 2018
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Pseudoexfoliation syndrome (PEX) is characterized by the deposition of a distinctive fibrillar material in the anterior segment of the eye and was first described in 1917 by Lindberg. It is frequently associated with open angle glaucoma, known as pseudoexfoliation glaucoma, which is one of the most common identifiable forms of secondary open angle glaucoma worldwide. Despite extensive research, the exactchemical nature of the fibrillar material is unknown. It is believed to be secreted multifocally in the iris pigment epithelium, the ciliary epithelium, and the peripheral anterior lens epithelium.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date March 14, 2021
Est. primary completion date December 2020
Accepts healthy volunteers No
Gender All
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Phakic patients presenting to Ophthalmology outpatient clinic Of Assiut University Hospital.

Exclusion Criteria:

- Patients with previous intraocular surgery.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
slit lamp
Presence of white grayish exfoliation material on the anterior lens capsule and / or the pupillary margin. Poor pupillary dilatation due to atrophy of the dilator pupillae muscle. The presence of pseudoexfoliative material (PXF)in cilliary processes and zonules. presence of PXF material scattered on corneal endothelium. Flecks of the exfoliative material on the anterior chamber which leads to glaucoma.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Outcome

Type Measure Description Time frame Safety issue
Primary the percentage of diabetic patients with pseudo-exfoliation syndrome slit lamp examination of all diabetic patients to get the percentage of those with pseudo-exfoliation syndrome 10 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT05158699 - Effectiveness of Periocular Drug Injection in CATaract Surgery Phase 3
Completed NCT04072939 - Retinal Detachment After Lens Surgery in the Nearsighted
Terminated NCT04969406 - A Prospective Trial of the Intelon BOSS(TM) System N/A
Active, not recruiting NCT01763411 - Visual Performance of Pseudophakic Patient With Different Intraocular Lenses N/A
Completed NCT00576485 - Spherical Aberration and Contrast Sensitivity in IOLs Phase 4
Recruiting NCT05290896 - Correlations Between Lens Star and Phacoemulsification. N/A
Completed NCT03655743 - PRO Measure for Refractive Surgery IRAS Project Number 246072
Completed NCT05368870 - Accuracy of Intra Ocular Lens CARLEVALE Calculation